¼¼°èÀÇ º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)
Global Beta Thalassemia Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
»óǰÄÚµå
:
1342786
¸®¼Ä¡»ç
:
Value Market Research
¹ßÇàÀÏ
:
2023³â 08¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 199 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç(Beta Thalassemia Testing) ½ÃÀå ¼ö¿ä´Â 2022³â 5,018¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. 2030³â 1Á¶ 2,146¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀ̸ç, 2023³âºÎÅÍ 2030³â±îÁö 9.2%ÀÇ CAGR ¼ºÀå·üÀ» º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.
º£Å¸ ÁöÁßÇØºóÇ÷Àº Ç÷¾× ÁúȯÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. À̰ÍÀº ½Åü¿¡ »ý¼ºµÇ´Â Çì¸ð±Û·ÎºóÀÌ ÀϹݺ¸´Ù ÀûÀº À¯Àüº´ÀÔ´Ï´Ù. Çì¸ð±Û·ÎºóÀº öÀ» Æ÷ÇÔÇÏ´Â ´Ü¹éÁú·Î ÀûÇ÷±¸¿¡ Á¸ÀçÇÕ´Ï´Ù. Çì¸ð±Û·ÎºóÀÇ ÁÖ¿ä ±â´ÉÀº Àü½Å ü¼¼Æ÷¿¡ »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â °ÍÀÔ´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷Àº ¾öû³ ¼öÀÇ Ç÷¾× ¼¼Æ÷°¡ ÆÄ±«µË´Ï´Ù. ÀÌ ÁúȯÀº ºóÇ÷, È£Èí °ï¶õ, ÇǷΰ¨, ºü¸¥ ½ÉÀå ¹Úµ¿, °ú¹Î¼º, Ȳ´Þ ¹× ¼ºÀå Áö¿¬À» Ư¡À¸·Î ÇÕ´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç¿¡´Â ¼öÇ÷°ú ö ų·¹ÀÌÆ® ¿ä¹ýÀÌ ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ:
ÁöÁßÇØºóÇ÷ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÏ ¼ö ÀÖ½À´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷ ½ÃÀå ¼ºÀå·ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº °Ç° °ü¸® ÁöÃâ Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ Á¶±âÀ¯Àü °Ë»ç¿Í »ó´ã µµÀÔ·ü »ó½ÂÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÕ´Ï´Ù. ¶ÇÇÑ, ÁöÁßÇØºóÇ÷ ÀνÄÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎ Á¶Ä¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, R&D Ȱµ¿ Ȱ¼ºÈ¿Í È¿°úÀûÀÎ Ä¡·á¹ý Ãâ½Ã´Â À¯¸®ÇÑ ½ÃÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ ¼³¹® Á¶»ç º¸°í¼´Â Porter's Five Forces ºÐ¼® ¸ðÇü, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°è ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØÀÇ °æÀïµµ¸¦ Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç »ê¾÷ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.
Áö¿ª ºÐ¼® :
ÀÌ ¼½¼ÇÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä« ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ª °³º° ÀÀ¿ë ºÐ¾ß ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.
¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì ±¸±Û¿¡ ¹®ÀÇ ¹Ù¶ø´Ï´Ù. ´ç»ç ¼³¹®Á¶»çÆÀÀº °í°´ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇÏÀ̶óÀÌÆ®
- ½ÃÀå ÇöȲ
Á¦3Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç-»ê¾÷ ºÐ¼®
- ¼Ò°³ : ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ
- ½ÃÀå ±âȸ
- ¾÷°è µ¿Çâ
- Porter's Five Forces ºÐ¼® ºÐ¼®
- ½ÃÀå ¸Å·Â ºÐ¼®
Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- ¿øÀç·á ºÐ¼®
- ¿øÀç·á ¸®½ºÆ®
- ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
- ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
- ÀáÀçÀû ±¸¸ÅÀÚ ¸ñ·Ï
- ¸¶ÄÉÆÃ Ã¤³Î
- Á÷Á¢ ¸¶ÄÉÆÃ
- °£Á¢ ¸¶ÄÉÆÃ
- ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ
Á¦5Àå COVID-19 ¹ß»ý ¿µÇ⠺м®
Á¦6Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : Á¦Ç°º°
- Á¦Ç°º° ÁÖ¿ä ¿ä¾à
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- Á¦Ç°º° ºÐ¼®
- ŰƮ
- ¼Ò¸ðǰ
Á¦7Àå ¼¼°èÀÇ º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : ±â¼úº°
- ±â¼úº° ÁÖ¿ä ¿ä¾à
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ±â¼úº° ºÐ¼®
- Ãâ»ý Àü Áø´Ü
- ¿ÏÀü Ç÷±¸ °è»ê
- DNA °Ë»ç
- ±âŸ
Á¦8Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : À¯Çüº°
- À¯Çüº° ÁÖ¿ä ¿ä¾à
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- À¯Çüº° ºÐ¼®
- ÁÖ¿ä »ì¶ó ¼¼¹Ì¾Æ
- Áß°£Çü »ç¶ó¼¼¹Ì¾Æ
Á¦9Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
- ÃÖÁ¾ »ç¿ëÀÚº° ÁÖ¿ä ¿ä¾à
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ÃÖÁ¾ »ç¿ëÀÚº° ºÐ¼®
- º´¿ø ¹× Àü¹® Ŭ¸®´Ð
- Áø´Ü¼¾ÅÍ
- ±âŸ
Á¦10Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå ºÐ¼® : Áö¿ªº°
- Áö¿ªº° Àü¸Á
- ¼Ò°³
- ºÏ¹Ì ¸ÅÃ⠺м®
- ÁÖ¿ä ¿ä¾à, ½ÇÀû°ú ¿¹Ãø
- ºÏ¹Ì : ºÎ¹®º°
- ºÏ¹Ì : ±¹°¡º°
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´ ¸ÅÃ⠺м®
- ÁÖ¿ä ¿ä¾à, ½ÇÀû°ú ¿¹Ãø
- À¯·´ : ºÎ¹®º°
- À¯·´ : ±¹°¡º°
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
- ÁÖ¿ä ¿ä¾à, ½ÇÀû°ú ¿¹Ãø
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- È£ÁÖ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
- ÁÖ¿ä ¿ä¾à, ½ÇÀû°ú ¿¹Ãø
- ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
- ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- Æä·ç
- Ä¥·¹
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
- ÁÖ¿ä ¿ä¾à, ½ÇÀû°ú ¿¹Ãø
- Áßµ¿, ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦11Àå º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ±â¾÷ °æÀï ±¸µµ
- º£Å¸ ÁöÁßÇØºóÇ÷ °Ë»ç ½ÃÀå °æÀï
- Á¦ÈÞ, Çù·Â, ÇÕÀÇ
- ÇÕº´, Àμö
- ½ÅÁ¦Ç° ¹ß¸Å
- ±âŸ °³¹ß
Á¦12Àå ±â¾÷ ÇÁ·ÎÇÊ
- »óÀ§ ±â¾÷ Á¡À¯À² ºÐ¼®
- ½ÃÀå ÁýÁßµµ
- MedGenome
- 3B BlackBio Biotech India Limited
- Bio-Rad Laboratories Inc.
- ViennaLab Diagnostics
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- BioMedomics Inc.
- Asper Biogene
- Tosoh Bioscience Inc.
NJH
¿µ¹® ¸ñÂ÷
The global demand for Beta Thalassemia Testing Market is presumed to reach the market size of nearly USD 1214.63 BN by 2030 from USD 501.83 BN in 2022 with a CAGR of 9.2% under the study period 2023 - 2030.
Beta thalassemia is a type of blood disorder. This is a genetic disease in which the body produces less haemoglobin than usual. Haemoglobin is a protein containing iron and is present in red blood cells; the major function of haemoglobin is to carry oxygen to the body cells throughout the body. Beta thalassemia causes a huge number of blood cells to be destroyed. The condition is characterized by anemia, shortness of breath, fatigue, fast heartbeat, irritability, jaundice, and slow growth. Beta thalassemia testing consists of blood transfusions and iron chelation therapy.
MARKET DYNAMICS:
The increase in the prevalence of thalassemia may be a major contributor to market growth. Another significant factor influencing the beta thalassemia market growth rate is the rising healthcare expenditure. Also, the rise in the adoption rate of early genetic testing and counselling will boost market growth. Moreover, government measures to raise awareness of thalassemia may propel market growth. Furthermore, increased R&D activities and the launch of effective treatments offer lucrative market opportunities. However, the high cost associated with the treatment may limit the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of beta thalassemia testing. The growth and trends of beta thalassemia testing industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the beta thalassemia testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Technology
- Prenatal Diagnosis
- Complete Blood Count
- Dna Testing
- Others
By Type
- Thalassemia Major
- Thalassemia Intermedia
By End-User
- Hospitals & Specialty Clinics
- Diagnostics Centers
- Others
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Beta Thalassemia Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the beta thalassemia testing market include MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics Inc., Asper Biogene, Tosoh Bioscience Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . BETA THALASSEMIA TESTING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Type
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY PRODUCT
- 6.1 Overview by Product
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Product
- 6.4 Kits Historic and Forecast Sales by Regions
- 6.5 Consumables Historic and Forecast Sales by Regions
7 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TECHNOLOGY
- 7.1 Overview by Technology
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Technology
- 7.4 Prenatal Diagnosis Historic and Forecast Sales by Regions
- 7.5 Complete Blood Count Historic and Forecast Sales by Regions
- 7.6 DNA Testing Historic and Forecast Sales by Regions
- 7.7 Others Historic and Forecast Sales by Regions
8 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TYPE
- 8.1 Overview by Type
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Type
- 8.4 Thalassemia Major Historic and Forecast Sales by Regions
- 8.5 Thalassemia Intermedia Historic and Forecast Sales by Regions
9 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY END-USER
- 9.1 Overview by End-user
- 9.2 Historical and Forecast Data
- 9.3 Analysis by End-user
- 9.4 Hospitals & Specialty Clinics Historic and Forecast Sales by Regions
- 9.5 Diagnostics Centers Historic and Forecast Sales by Regions
- 9.6 Others Historic and Forecast Sales by Regions
10 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
- 10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
- 10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
- 10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
- 10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE BETA THALASSEMIA TESTING COMPANIES
- 11.1. Beta Thalassemia Testing Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12 . COMPANY PROFILES OF BETA THALASSEMIA TESTING INDUSTRY
- 12.1. Top Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. MedGenome
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. 3B BlackBio Biotech India Limited
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Bio-Rad Laboratories Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. ViennaLab Diagnostics
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. Thermo Fisher Scientific Inc.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. PerkinElmer Inc.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
- 12.9. BioMedomics Inc.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
- 12.10. Asper Biogene
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
- 12.11. Tosoh Bioscience Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
°ü·ÃÀÚ·á